Samhan Ashraf, Rasmussen Carolyn A, Prada Carlos E, Cremer Paul C, Mandelin Arthur M, Al-Kazaz Mohamed
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Division of Genetics, Genomics and Metabolism, Lurie Children's Hospital, Chicago, Illinois, USA.
JACC Case Rep. 2025 Apr 16;30(8):103206. doi: 10.1016/j.jaccas.2024.103206. Epub 2025 Feb 12.
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is a rare hereditary autoinflammatory disorder caused by mutations in the tumor necrosis factor superfamily member 1A gene, which encodes tumor necrosis factor receptor 1. It typically presents with recurrent fever and other signs of inflammation.
A 26-year-old Hispanic woman presented with recurrent fever, tachycardia, and pleuritic chest pain. She was diagnosed with recurrent pericarditis (RP) secondary to TRAPS. She showed an excellent clinical response upon switching from canakinumab to rilonacept.
RP is often labeled idiopathic, but autoinflammatory diseases such as TRAPS should be considered in such cases on the basis of the clinical presentation. Interleukin-1 inhibitors have emerged as promising treatments for RP, with radical pericardiectomy being considered as a last resort.
肿瘤坏死因子受体相关周期性综合征(TRAPS)是一种罕见的遗传性自身炎症性疾病,由肿瘤坏死因子超家族成员1A基因突变引起,该基因编码肿瘤坏死因子受体1。其典型表现为反复发热及其他炎症迹象。
一名26岁的西班牙裔女性出现反复发热、心动过速和胸膜炎性胸痛。她被诊断为继发于TRAPS的复发性心包炎(RP)。从卡那单抗换用利洛纳塞后,她显示出良好的临床反应。
RP常被标记为特发性,但基于临床表现,此类病例应考虑诸如TRAPS等自身炎症性疾病。白细胞介素-1抑制剂已成为RP的有前景的治疗方法,根治性心包切除术被视为最后的手段。